Form 4 for IMDX Insight Molecular Diagnostics Inc.
Accepted 2022-03-15 00:00:00 ET · period of report 2022-03-15 · accession 0001493152-22-006879 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-15 | 2022-03-15 | IMDX | Levine Mitchell S | CFO | P - Purchase | $1.17 | +25.0K | 87.1K | +40% | +$29.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, no par value | 2022-03-15 | P | A | 25,000 | $1.17 | 87,080 | D | — | — | (F1) The price of $1.166 per share represents a weighted average of prices ranging from $1.155 to $1.180 per share. The reporting person undertakes to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased or sold at each separate price. |